Here's Why Momentum in Amneal (AMRX) Should Keep going - Yahoo Finance
5 hours ago • Google News
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 2.83B
P/E Ratio
902.00
Revenue (TTM)
$ 2.85B
Volume
0
52W High
$ 9.47
52W Low
$ 6.68
Dividend Yield
0.00%
Beta
1.12
Technicals
50-Day MA
8.0519
200-Day MA
8.0712
52 Week High
9.475
52 Week Low
6.685
About AMRX
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products wor.
Employees
8300
Headquarters
Bridgewater, NJ
CEO
Mr. Chirag K. Patel